parkin-induced defects in neurophysiology and locomotion are generated by metabolic dysfunction and not oxidative stress by Vincent, Amanda et al.
parkin-induced defects in neurophysiology
and locomotion are generated by metabolic
dysfunction and not oxidative stress
Amanda Vincent, Laura Briggs, Griff F.J. Chatwin, Elizabeth Emery, Rose Tomlins,
Matt Oswald
{, C. Adam Middleton, Gareth J.O. Evans, Sean T. Sweeney and
Christopher J.H. Elliott∗
Department of Biology, University of York, PO Box 373, York YO10 5YW, UK
Received October 26, 2011; Revised and Accepted December 21, 2011
Parkinson’s disease (PD) is characterized by movement disorders, including bradykinesia. Analysis of inher-
ited, juvenile PD, identiﬁed several genes linked via a common pathway to mitochondrial dysfunction. In this
study, we demonstrate that the larva of the Drosophila parkin mutant faithfully models the locomotory and
metabolic defects of PD and is an excellent system for investigating their inter-relationship. parkin larvae dis-
played a marked bradykinesia that was caused by a reduction in both the frequency of peristalsis and speed
of muscle contractions. Rescue experiments conﬁrmed that this phenotype was due to a defect in the ner-
vous system and not in the muscle. Furthermore, recordings of motoneuron activity in parkin larvae revealed
reduced bursting and a striking reduction in evoked and miniature excitatory junction potentials, suggesting
a neuronal deﬁcit. This was supported by our observations in parkin larvae that the resting potential was
depolarized, oxygen consumption and ATP concentration were drastically reduced while lactate was
increased. These ﬁndings suggest that neuronal mitochondrial respiration is severely compromised and
there is a compensatory switch to glycolysis for energy production.
parkin mutants also possessed overgrown neuromuscular synapses, indicative of oxidative stress, which could
be rescued by overexpression of parkin or scavengers of reactive oxygen species (ROS). Surprisingly, scaven-
gers of ROS did not rescue the resting membrane potential and locomotory phenotypes. We therefore propose
that mitochondrial dysfunction in parkin mutants induces Parkinsonian bradykinesia via a neuronal energy def-
icit and resulting synaptic failure, rather than as a consequence of downstream oxidative stress.
INTRODUCTION
The recognition of Mendelian inheritance in some forms of
Parkinson’s disease (PD) has revolutionized our understanding
of the causation of this disease (1). Mutations in PD-related
genes (e.g. parkin, a-synuclein, PINK1, LRRK2) have now
been replicated in a range of model organisms (2). Drosophila
models share many features with the human disease, including
the loss of dopaminergic neurons in the central nervous system
(CNS) and reduced locomotion. Other similarities are evident
at the cellular level, particularly mitochondrial malfunction
and disorganization (3–5). The advanced ﬂy genetic toolbox
(6) has also facilitated deep insights into the cellular and meta-
bolic pathways in which the PD-related gene products partici-
pate. A key result has been the identiﬁcation of a single
cellular pathway focussing on 4E-BP, to which several
genes (parkin, PINK1 and LRRK2) contribute (7), suggesting
the potential for novel drug therapies across several genotypes.
Apart from dopaminergic cell death, few Drosophila studies
have analysed neuronal phenotypes, focusing instead on
spermatozoa, eye or muscle. Our ﬁrst focus, therefore, is
what are the neurophysiological (rather than muscle) defects
that lead to reduced locomotion? For this, we turned our atten-
tion to the larval (juvenile) system, as it helps us understand
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neuromuscular junction is one of the best-characterized synap-
ses (8). It is essential for normal movement. Here, we describe
our ﬁnding that parkin mutant larvae have defective locomo-
tion, with a bradykinesia-like phenotype. This is accompanied
by reduced resting and synaptic potentials. The inability to
maintain the normal muscle resting potential suggested that
the mitochondria could not produce enough ATP: indeed,
we ﬁnd that parkin larvae have reduced ATP and oxygen con-
sumption. Furthermore, they have elevated lactate, indicating
that glycolysis may be elevated in response to the ATP deﬁcit.
Our second question is how does oxidative stress relate to
mitochondrial dysfunction? Fly models of PD are highly sen-
sitive to oxidative stress, for example to paraquat (9,10), and
are rescued by overexpression of genes that reduce reactive
oxygen species (ROS) (11–14). It has recently been recog-
nized that oxidative stress induces autophagy and synaptic
overgrowth (15,16). We ﬁnd that parkin mutants indeed
have synaptic overgrowth, and this is rescued by over-
expression of ROS scavengers as well as by parkin.
However, as we ﬁnd that ROS scavengers do not rescue the
locomotion or electrophysiological defects, we are genetically
separating the fundamental parkin deﬁcit of energy production
from its downstream oxidative stress consequences.
RESULTS
parkin larvae move slowly
The tracks of parkin mutant larvae crawling across an agar
plate are shorter for animals migrating for a set interval of
time (2 min) than wild-type as the parkin larvae move more
slowly (Fig. 1A). Their mean speed is reduced to 62% of
the wild-type. The parkin heterozygote crawls at the same
speed as the wild-type, as would be expected from this reces-
sive mutation. Using the GAL4/UAS system, we tested for
rescue by global expression of wild-type parkin in the
mutant background and found the velocity to be fully restored.
As parkin mutants have both neuronal (11) and muscle (17)
phenotypes, we then tested for tissue-speciﬁc rescue using
neuronal (using elav GAL4) and muscle (G14 GAL4)
drivers. The neuronal driver rescued locomotion to wild-type
levels, but no signiﬁcant rescue was achieved with the
muscle driver (Fig. 1B). We conﬁrmed the data from
Figure 1 using two additional wild-types, a second heterozy-
gote and two other parkin mutant combinations, with both
the park
25 homozygote null and park
z3678 hypomorph crawling
more slowly than the other genotypes (CS, w
2, CS/park
25,
nested ANOVA, parkin versus wild-types; F1,113 ¼ 34, P ,
0.001). Further conﬁrmation of the role of neuronal parkin
in locomotion was provided by using the same drivers to
test for rescue in the park
25 homozygote background. The
global (Act5C GAL4) or neuronal drivers gave partial rescue
(71% and 77%, respectively, nested ANOVA F77,1 ¼ 7.4, P
¼ 0.008) but no rescue was seen using the muscle driver
(mean larval speed 93% of the park
25 homozygote,
ANOVA, Bonferroni post hoc test, P ¼ 1.0).
We assayed the strength and frequency of peristaltic con-
tractions directly, using a larval length assay, in which a
restrained larva pulls on a ﬂexible beam (Fig. 2A). Wild-type
larvae pulled regularly on the beam, while the parkin knock-
outs had a reduced frequency of contractions (32% of wild-
type; Fig. 2B and D). However, the peak–peak change in
length did not differ between the wild-type and parkin null
(Fig. 2C). This suggests that the reduced velocity of the
larvae was due to less frequent steps, rather than a reduced
step size. A particular feature of the parkin larval contractions
was the slow rate at which the larva shortens, akin to bradyki-
nesia (Fig. 2B). We also tested for rescue by neuronal or
Figure 1. Larval locomotion is reduced in parkin mutants. (A) Tracks of
parkin transheterozygotes crawling for 2 min are shorter than those of wild-
type. (B) Quantiﬁcation shows that the mean velocity of the parkin mutant
is 62% of wild-type (Bonferroni post hoc comparison: P ¼ 0.003). A signiﬁ-
cant rescue is seen with the expression of wild-type parkin in the transheter-
ozygote background using the global or neuronal drivers but not with the
muscle driver (Bonferroni post hoc tests: P ¼ 0.009, 0.003, 0.253, respective-
ly). At least 10 larvae of each genotype, total 130. Genotypes—wild-type: CS/
w
2; heterozygote: CS/park
z3678; parkin: park
25/park
z3678. Drivers—global:
Act5C; neuronal: elav
3EI; muscle: G14. All rescue experiments are in
park
25/park
z3678 background.
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tion frequency to wild-type levels (Fig. 2D).
The peristaltic longitudinal muscles are innervated by seg-
mental nerves arising from the ventral nerve cord. To
examine the neural input to the muscles, we severed all the
segmental nerves and used a suction electrode on a segmental
nerve to record the efferent activity of the motoneurons. The
wild-type nerve recordings showed regular bursts of action
potentials, along with occasional periods of tonic activity
(Fig. 3). In the parkin null, the frequency of bursts was signiﬁ-
cantly reduced (to 44% of wild-type; Fig. 3B).
parkin larvae have reduced resting and synaptic
membrane potentials
The muscles used in locomotion include the longitudinal body
wall muscles 6 and 7. Since their neuromuscular junction is
easily accessible, it has been extensively studied, and is now
a model synapse (8,18). These muscles are innervated by
two motoneurons, so that intracellular recordings from them
usually show two sizes of synaptic potentials (19). These are
called the Is and Ib excitatory junction potentials (EJPs),
though the motoneurons can also be recruited together to
produce a composite EJP. Both types of EJPs were present
in both the parkin muscles (Fig. 4A), but the parkin mutant
showed signiﬁcant differences from wild-type.
First, the resting potential of muscles 6/7 was much
more positive in the parkin larvae than in the controls
(Fig. 4A–C): the wild-type resting membrane potential
(RMP) is 263.6+1.7 mV (mean+SE) and the mean
parkin 252.9+1.0 mV. We conﬁrmed these data in an inde-
pendent sample of 292 muscles from two wild-type controls
(CS, CS/w
2) and two parkin genotypes (park
25/park
25,
park
25/park
Z3678), where the mean difference in RMP was
12.3 mV (nested ANOVA F291,1 ¼ 168, P , 0.001).
Secondly, the size of the EJP was reduced in the parkin
mutants. The parkin knockout might be expected to show
smaller synaptic potentials in any case, because the membrane
potential of the parkin knockout is more positive, and there-
fore closer to the synaptic reversal potential. However, in
recordings made at the same RMP, the parkin larvae still
had smaller EJPs than the wild-type control. This is shown
in Figure 4Ci, where the size of the EJP is plotted as a function
of the RMP. The regression line for the wild-type data lies
above the regression line for the parkin mutants.
Figure 2. Locomotor contractions are less frequent in parkin larvae. (A)A
larval extensometer, constructed from a ﬂexible photobeam and quadrant
photodiode. (B) Peristaltic waves recorded by the extensometer show that con-
tractions are fewer in parkin knockouts than in wild-type, but the peak–peak
excursion is not affected. (C) The mean force is the same in wild-type and
parkin knockout (ANOVA: F1,27 ¼ 2.8, P ¼ 0.10). (D) The frequency of peri-
staltic contractions is reduced in the parkin knockout (ANOVA, Bonferroni
post hoc test, P , 0.001), and completely rescued by neuronal expression of
wild-type parkin in nerve (Bonferroni post hoc test versus parkin P ¼ 0.014;
versus wild-type P ¼ 0.56). Expression in muscle is ineffective (Bonferroni
P ¼ 0.38). Genotypes and number of larvae—wild-type: CS 13; parkin:
park
25/park
25 15; drivers: neuronal: elav
3EI 10; muscle: G14 12. Rescues are
in park
25/park
25 background.
Figure 3. Central pattern generator activity is reduced in parkin knockout. (A)
The frequency of bursts in the motoneurons is reduced in the parkin knockout,
with the wild-type showing a regular rhythm (and occasional long bursts),
while the parkin mutant is much quieter. (B) The reduction (mean: 56%) is
signiﬁcant (ANOVA F1,9 ¼ 6.1, P ¼ 0.039). Genotypes—wild-type: CS;
parkin: park
25/park
25.
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using larvae raised on the same batch of food, and tested for
rescue of the resting and synaptic potentials by expressing
wild-type parkin in nerve or muscle in the transheterozygote
background (Fig. 4B, Cii). Muscle expression of parkin in
the transheterozygote background rescued the muscle RMP
by 6.2+1.5 mV (60% of the deﬁcit), but not the synaptic po-
tential, although these data come from the same larvae. On the
other hand, the neuronal expression of wild-type parkin did
not affect the RMP, but did rescue the size of the synaptic po-
tential by 2.0+0.8 mV. (Here we note that the choice of G14
and elav
3E1 drivers clearly separated the neuronal and muscle
phenotypes.)
The larval neuromuscular junction also shows miniature
EJPs (mEJPs): using data from preparations with matched
RMPs, the mEJPs from parkin transheterozygotes were
smaller than those from wild-type larvae (modal amplitude:
0.5 and 0.7 mV, respectively; Fig. 5).
parkin larvae show compromised respiration
The failure to maintain the RMP along with data from adults
showing defective mitochondrial ﬁssion/fusion (17,20) sug-
gested that the rate at which parkin larvae generate ATP by
aerobic respiration might be reduced. In order to address this
we used two separate technologies—capillary respirometer
or an oxygen electrode. The capillary respirometer allows us
to follow gas exchange in air, while the oxygen electrode,
using larvae immersed in HL3 solution, allows us to
examine the impact of respiratory poisons on oxygen
Figure 4. Resting and synaptic potentials are reduced in parkin mutants. (A) Intracellular recordings from larval muscles show the more positive resting potential
in the parkin larvae along with smaller EJPs, than in the control, wild-type larva. Both traces show two sizes of spontaneous EJPs: the large ones are called type
Is, and the small ones type Ib; additional compound EJPs were also frequently recorded. (B) The mean muscle resting membrane potential (RMP) in the parkin
mutant is 10.7+1.7 mV more positive than the wild-type control (Bonferroni post hoc estimate, P , 0.001). Expressing wild-type parkin in this transhetero-
zygote background using a neuronal driver did not rescue the RMP deﬁcit (Bonferroni P ¼ 1.0), but using a muscle-speciﬁc driver a signiﬁcant rescue was seen
(Bonferroni post hoc estimate, 6.2+1.5, P ¼ 0.001). (C) EJPs (type Is) are smaller in parkin mutants than in controls. (i) For each genotype, EJPs are smaller at
more positive RMPs, but at any given RMP, EJPs from control muscles are bigger than those from parkin mutants as indicated by the regression lines. (ii) We
tested for rescue as follows: we calculated the parkin regression line to provide the expected size of the EJP in each preparation, and calculated the difference of
the observed EJP from this expected value. Expressing parkin neuronally in this mutant background partially rescued the EJPs (t13 ¼ 2.6, P ¼ 0.023), but no
rescue was seen with muscle expression (t12 ¼ 0.46, P ¼ 0.65). As a control, we checked that the wild-type EJPs are signiﬁcantly bigger than expected from
the parkin regression line (one-sample t-test: t10 ¼ 6.8, P , 0.001). Data from the same set of muscle recordings as (B); 63 EJPs at least 11 in each genotype.
Genotypes—wild-type: CS/w
2; parkin: park
25/park
z3678. Drivers—neuronal; elav
3EI; muscle—G14. Rescues are all in park
25/park
z3678 background.
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larvae had 70% of the oxygen consumption of the wild-type
controls (Fig. 6Ai,ii). parkin larvae were also more sensitive
to metabolic poisons: 6 mM cyanide blocked parkin oxygen
consumption completely, but reduced only wild-type respir-
ation by 40%, while 6 mM iodoacetate blocked 62% of wild-
type respiration, and 87% of parkin oxygen consumption
(Fig. 6Aii). The ATP levels of the parkin knockout larvae
were reduced to 14% of the wild-type value (Fig. 6B) and
the lactate concentration was nearly doubled (+80%,
Fig. 6C). We also obtained similar data in the park
25/
park
Z3678 transheterozygotes (mean increase in lactate over
wild-type, 88%).
ROS scavengers rescue overgrown synapses, but not
membrane potential or locomotor defects in parkin larvae
Oxidative stress is frequently associated with PD (in both the
human disease and model organisms). Since oxidative stress
leads to synaptic overgrowth (16), we counted the synaptic
boutons on muscle 6/7 of the third instar parkin larvae, as
this provides a convenient index of the synapse size. The
sample images from the neuromuscular junctions of parkin
transheterozygotes showed more boutons than those from
micrographs of wild-type (CS) larvae (Fig. 7A). The average
data for boutons/muscle surface area showed that Drosophila
larvae that are null for parkin have  50% more synaptic
boutons than the wild-type controls and heterozygote
(Fig. 7B). We conﬁrmed this increase by examining two
other wild-type strains (w
2, yw), a second heterozygote and
three other parkin mutant combinations: the mean increase
was 51+4% (nested ANOVA F1,371 ¼ 73, P , 0.001). The
raw bouton counts from parkin mutants were also greater
than wild-type (mean increase 18%, nested ANOVA,
F1,143 ¼ 37, P , 0.001). To conﬁrm that the increase in
boutons is due to the parkin knockout, the wild-type parkin
was expressed in the parkin background, giving a complete
rescue of the synaptic overgrowth phenotype (Fig. 7B). Both
neuronal and muscle drivers also gave complete rescue of
the synaptic overgrowth (Fig. 7B). We conﬁrmed this data
in the transheterozygote background, where we ﬁnd that
both neuronal and muscle expression of parkin rescue the
synaptic overgrowth (ANOVA, Bonferroni post hoc tests,
P , 0.001, N ¼ 213).
Having demonstrated synaptic overgrowth, we wanted to
examine the role of oxidative stress in the parkin phenotype.
Overexpression of genes that scavenge free radicals (super-
oxide dismutase, catalase) signiﬁcantly rescued the over-
growth phenotype, down from 53% to 20% more than the
wild-type (Fig. 8A). In contrast to these data, we found no
rescue of either the muscle RMP or the larval locomotory
defect with expression of any of these scavengers (Fig. 8B
and C).
DISCUSSION
We have found that the parkin gene knockout and hypomorph
have reduced locomotion due to slower movement resembling
bradykinesia, reduced synaptic potentials, decreased quantal
size, more positive RMP, lower oxygen consumption,
reduced ATP and increased lactate, along with overgrown
synapses. Our results provide a key description of the inter-
related actions of a PD-related gene on the electrophysiology,
anatomy and respiration of the most genetically tractable
model organism, open to cellular and molecular analysis.
Although several laboratories have generated parkin knock-
outs and hypomorphs (9,17,21,22), only adult phenotypes
were reported previously. This is the ﬁrst report of larval
defects associated with mutations in this early-onset gene.
Indeed, one group speciﬁcally mentioned that they detected
no larval phenotype (9). Unlike these groups, we obtain few
adult park
25 or park
Z3678 homozygotes, so we suspect that
the severity of parkin phenotypes is affected by differences
in food, possibly trace minerals (23,24) that modulate oxida-
tive stress.
Our key observation is that the neuronal parkin knockout
produces a bradykinesia-like reduction in locomotion. Others
have shown loss of mobility in geotaxic assays of adult ﬂies
following manipulation of PD-related genes in muscles
(11,25). We have taken this further by showing that the
larval deﬁcit is neuronal, not muscular as slower peristalsis
results from reduced activity in the motoneurons. We show
this by two ways: genetically and physiologically. Genetically,
we show that (in the early stages of the degeneration) the
nervous system is the main tissue affected by parkin as we
can rescue the locomotory and bradykinesia phenotypes by
neuronal expression of wild-type parkin. Physiologically, we
show that both synaptic transmission and central pattern
Figure 5. Miniature excitatory junction potentials (mEJPs) are smaller in
parkin mutants than in wild-type larvae. (A) Traces from parkin and wild-type
larvae. (B) Histograms of the amplitude of 550 mEJPs taken from 13 muscles,
matched for resting membrane potential (RMP), show that peak amplitude is
 2 mV smaller in the parkin larvae (Kolmogorov–Smirnov test statistic 3.5,
P , 0.001). RMP—wild-type: 263.8+1.1, n ¼ 7; parkin: 263.0+0.85, n
¼ 6. Genotypes—wild-type: CS/w
2; parkin: park
25/park
z3678.
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activity may result from reduced neurotransmission. The
CPG may also be slowed by pumping deﬁcits, as the low
levels of ATP will increase the time taken to correct the
ionic imbalance that builds up in neurons during each peristal-
tic wave (26). In addition, locomotion is also modulated by
aminergic (dopamine, serotonin etc) neurons that depend on
the Drosophila vesicular aminergic transporter (DVMAT).
Mutations in this gene severely slow crawling (27). Since
adult data show an interaction of DVMAT with parkin (21),
so too, may larval bradykinesia result from parkin-induced
disruption of aminergic transmission.
The smaller EJPs and mEJPs in the parkin knockout indi-
cate a reduction in synaptic transmission. This is most likely
to result from reduced glutamate release—perhaps, as a
result of problems with its transport into vesicles in an ATP-
dependent manner. The recent suggestion that parkin may
affect transmission through its interaction with endocytic
proteins, e.g. endophilin-A (28) is unlikely to explain our
data: although parkin is known to function as a ubiquitin E3
ligase, failure of parkin to ubiquitinate and so degrade endo-
philin is unlikely to reduce synaptic transmission. A third pos-
sibility is that the motoneuron, like the muscle, has a more
positive resting potential and this affects the dynamics of glu-
tamate release. Finally, we note that the neuronal rescue did
not fully restore the size of the EJP, so that a reduction in
muscle impedance or post-synaptic ionic dynamics may also
contribute to the reduction in synaptic transmission. Although
the original descriptions of the phenotype of parkin null mice
were divergent (29), more recent evidence indicates that these
mice do have reduced dopamine release at striatal synapses
(30). At the ﬂy neuromuscular junction, manipulations of
another PD-related gene, LRRK2, and its Drosophila homo-
logue dLRRK, show complex effects on synaptic transmission.
These include a reduction in synaptic transmitter release in the
dLRRK knockout (31). However, the other effects of LRRK2
Figure 6. parkin larvae have reduced aerobic metabolism and compensate with increased glycolysis. (A) Reduction in oxygen consumption. (i) Measurement
with a capillary respirometer shows that the oxygen consumption is 70% of the parkin larvae than in the wild-type larvae (ANOVA F17,1 ¼ 22.8, P , 0.001). (ii)
Measurement with an oxygen electrode conﬁrms that the oxygen consumption of parkin is 70% of wild-type (ANOVA F23,1 ¼ 78, P , 0.001). Addition of 6 mM
cyanide or iodoacetate reduces respiration, having a bigger impact on the parkin than the wild-type larvae. Data normalized to wild-type as 100%. (B) The ATP
concentration is lower in parkin than in the wild-type larvae (ANOVA F15,1 ¼ 104, P , 0.001). (C) The lactate concentration is higher in the parkin than in the
wild-type controls (ANOVA F23,1 ¼ 16, P ¼ 0.001). Data normalized as moles lactate/gram of protein, with wild-type as 100%. Genotypes—wild-type: CS;
parkin: park
25/park
25.
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genes may not always be acting through a common cellular
mechanism.
The more positive RMP in our parkin larvae is most likely
to be due to a reduction in ATP synthesis, which requires
oxygen. We have demonstrated this using two techniques to
record O2 consumption and by measuring ATP levels directly.
A similar reduction in ATP production (by 58%) is reported in
human ﬁbroblasts from patients with parkin mutations (32).
Low ATP will lead to reduced pumping of ions across the
membrane and so a more positive RMP (although this may
be counteracted by increased opening of ATP-sensitive potas-
sium channels (33)). Reports of Drosophila mutants with a
more positive membrane potential are rare, but in one, the
phosphoglycerate kinase mutant, nubian, this is due to
reduced ATP levels (34). In the parkin knockout, we predict
that neurons (as well as muscles) will also have a more posi-
tive membrane potential because the mutation is expressed
globally.
The reduction of oxygen consumption indicates severe
mitochondrial dysfunction; not surprising in the light of the
reports of deﬁcient mitochondrial ﬁssion/fusion and mitochon-
drial swelling in a range of ﬂy models of PD (3,17,20,35). The
parkin larvae respond to this by increasing glycolysis, as indi-
cated by the increase in lactate levels. Increased lactate has
been reported in some PD patients (36), but not in others
(37). This discrepancy might be due to a general increase in
lactate (and changes in anaerobic metabolism) with age (38),
and so our data, along with improvements in genotyping and
other molecular techniques may make the role of glycolytic
biomarkers in the progression of PD worth revisiting.
Mitochondrial dysfunction will also induce oxidative stress.
A key response to oxidative stress is the induction of autop-
hagy (15), which causes increased growth of neuronal term-
inals (16). As with our parkin, so also manipulations of a
second PD-related gene, dLRRK cause overgrowth of the
larval neuromuscular junction (31). We note that, in both
transgenics, the overgrowth phenotype is effectively rescued
by global, neuronal or muscle expression of wild-type
protein. This shows a difference from our physiological and
locomotor phenotypes, which were rescued by neuronal—
but not muscle—expression of parkin.
We ﬁnd excellent rescue of the neuronal overgrowth by re-
lieving oxidative stress. Increased expression of cytosolic
(catalase, superoxide dismutase 1) or mitochondrial (super-
oxide dismutase 2) enzymes that scavenge ROS are equally ef-
fective. Similarly, adult ﬂy models of PD are rescued by
overexpression of genes that reduce ROS, e.g. glutathione
S-transferase or thioredoxin (11–14).
However, over-expressing oxidative stress transgenes
rescues only the neuronal overgrowth; the RMP and locomotor
phenotype are not affected. (This is a major contrast to parkin
expression, which rescues each of the oxidative stress, RMP
and locomotor phenotypes.) Thus, expression of the ROS sca-
vengers exposes fundamental physiological deﬁcits, including
the failure to maintain the RMP and the failure of the neuronal
network of the CPG. In the same way, antioxidants like
vitamin E have powerful cellular actions, but are not generally
effective in the treatment of PD patients (39,40).
In conclusion, we ﬁnd that parkin mutants recapitulate the
bradykinesia symptoms of PD, and we suggest that this is
due to an energy deﬁcit rather than oxidative stress. parkin-
Dependent mitochondrial dysfunction reduces ATP levels
and the ability of neurons to maintain an RMP. Oxidative
stress has received considerable attention as a target for treat-
ing ageing and neurodegenerative disorders; however, this
Figure 7. Overgrown synapses are characteristic of parkin mutants. (A) There
are more boutons (white) in the parkin neuromuscular junction than in the
control wild-type. Images from confocal stacks of synaptic terminals on
muscles 6 and 7 stained with horseradish peroxidase antibody (HRP,
magenta) show the neuronal membrane and with synaptotagmin (SYT,
green) antibody to show the terminal boutons. (B) Quantiﬁcation of the
bouton count at 372 synapses conﬁrms that parkin mutants have excess
boutons (+53%, Bonferroni P , 0.001). Expression of wild-type parkin by
the global, neuronal or muscle drivers achieves substantial rescue of the syn-
aptic overgrowth (down to 3% above the control values, Bonferroni compari-
son with wild-type each ¼ 1.0). There is no signiﬁcant difference between the
synaptic overgrowth in the three rescues (ANOVA, F2,78 ¼ 0.81, P , 0.445).
At least 16 neuromuscular junctions for each genotype, totally 223. Data nor-
malized as ratio of boutons/muscle area, with wild-type as 100%. Genotypes—
wild-type: CS; parkin: park
25/park
25. Drivers—global: Act5C; neuronal;
elav
3EI; muscle: G14. Rescues are in park
25/park
25 background.
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target for the treatment of PD.
MATERIALS AND METHODS
Flies
Flies were routinely raised at 258C. Wild-type ﬂies (Canton-S,
CS and w
2, w
1118) were obtained from our laboratory stocks,
while the parkin
25 (17), parkin
Z3678 (11) and UAS-parkin
C2
(wild-type Drosophila parkin (11)) lines were a gift from
Alex Whitworth & Leo Pallanck. The G14 GAL4 line (from
Akinao Nose, Tokyo), UAS stocks and Actin5C and elav
3E1
GAL4 lines (from the Bloomington Stock centre) were recom-
bined with the parkin lines as required. All experiments were
performed on the third instar larvae, selected as they crawled
on the side of the vial or over the surface of the food.
In all experiments, we ﬁnd signiﬁcant differences between
the Canton-S (CS) wild-type and park
25/park
25 null. When
we compare the wild-type outcross, CS/w
2 and the park
25/
park
Z3678 transheterozygote, we observe the same effects.
All the parkin rescue experiments were performed both in
the null background and the transheterozygote background;
we ﬁnd no differences due to background.
Larval locomotion
Larval locomotion was recorded using our standard procedure
(41). Larval progress across a horizontal agar-ﬁlled Petri dish
was recorded on to a computer disk for 2 min at a frame rate of
12 frames/min. Positions were determined using the MTrack2
plugin (42) (see also online http://valelab.ucsf.edu/~nico/IJp
lugins/MTrack2.html) to ImageJ (http://rsbweb.nih.gov/ij/).
Larval length assay
Larval length assay was performed as described recently (41).
A larva pulls on a ﬂexible plastic optical pipe, through which
the beam of a red LED is transmitted onto a photodetector.
The four optosensors in the detector allow the linear move-
ment of the beam to be computed, with the signal recorded
on computer disk at 0.1 Hz.
Saline solution
All experiments were performed in HL3 solution (43). Com-
position in millimolars—sodium chloride, 70; potassium
chloride, 5; calcium chloride, 1; sodium hydrogen carbonate,
10; BES (N,N-bis(2-hydroxyethyl)-2-aminoethanesulphonic
acid), 5; trehalose, 5; sucrose, 115; pH 7.5.
Figure 8. In the parkin null background, overexpression of oxidative stress
transgenes rescues synaptic overgrowth but not muscle RMP or larval locomo-
tion. (A) The normalized bouton count is reduced from the parkin mutant peak
( +50% of the CS wild-type) to +20% by overexpression of catalase or
superoxide dismutase (Sod1 or Sod2) with a global driver. The effect of the
oxidative stress transgenes is signiﬁcant (Bonferroni comparison with parkin
P , 0.001 for each transgene). At least 24 neuromuscular junctions for each
genotype, totally 224. (B) Oxidative stress gene overexpression did not
rescue the muscle RMP (comparison with parkin mutants, Bonferroni tests
all P ¼ 1.0). At least 18 muscles for each genotype, 213 in total. (C) The oxi-
dative stress gene overexpression did not rescue larval locomotion (compari-
son with parkin mutants Bonferroni tests all P ¼ 1.0). At least 12 larvae for
each genotype, total 171. Genotypes—(A and C) wild-type: CS; parkin:
park
25/park
25 outcrossed to the Act5C driver used to express each transgene
in park
25/park
25 background. (B) Wild-type CS/w
2; parkin; park
Z3678/
park
25, transgene expression driven by the Act5C driver.
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Segmental nerve recordings were made by dissecting open the
larva in HL3 saline, and removing its gut, fat body and
reproductive organs. The segmental nerves were all severed
and the CNS end of one drawn up into a glass suction
pipette. The signal was ampliﬁed 1000 times and recorded
on disk at 10 kHz.
Intracellular recording from the longitudinal muscles
Intracellular recording from the longitudinal muscles 6/7
was made with sharp glass micropipettes, with tip resistance
10–15 MV. A high-resistance input 50× ampliﬁer was
used, and data stored on computer disk at 5 kHz. All data
were recorded in HL3 saline. Spontaneous EJPs were recorded
from preparations in which the CNS was left in place with
intact innervation and the size of the large (Is) EJPs measured;
mEJPs were analysed in preparations from which the CNS had
been removed. Data from larvae with the RMP more positive
than 240 mV were discarded.
Oxygen consumption
Oxygen consumption was recorded with two techniques.
Firstly, using a capillary respirometer three larvae were
placed in an unﬁlamented borosilicate glass capillary (internal
diameter 1.16 mm, length 150 mm; Clark Electromedical,
Pangbourne, UK) and one end sealed with cotton wool/nail
varnish. Carbon dioxide was absorbed by  2 mg sodium hy-
droxide, and the volume change monitored by the movement
of a parafﬁn oil droplet. The respiratory quotient was deter-
mined from larvae tested with and without the hydroxide to
absorb carbon dioxide. No movement of the parafﬁn droplet
was seen in replicates without larvae. Experiments were all
performed at 218C. Secondly, using a Clark oxygen electrode,
in which larvae to a mass of 50 mg ( 30–40 larvae) were
placed in the recording chamber ﬁlled with 3 ml HL3 saline.
ATP and lactate were measured in larval haemolymph using
kits from proteinkinase.de (Kassel, Germany) and Eton Bios-
ciences Inc. (San Diego, USA), respectively, following the
manufacturers’ protocols. Bradford assays (44) were used to
measure the protein concentrations in the samples.
Synaptic boutons
Synaptic boutons were counted as described previously (16),
using a polyclonal synaptotagmin antibody to mark
synaptic-release sites and horseradish peroxidase antiserum
to mark the nerve membrane.
Statistics
Statistics were evaluated in SPSS. In experiments with mul-
tiple genotypes, ANOVA followed by post hoc tests were
used to compare two genotypes and nested ANOVA to
compare groups of related genotypes (e.g. all parkin lines
with all wild-type lines). Where Bonferroni probabilities are
reported, at least the same probability level was seen in the
Tukey HSD test. In the ﬁgures, NS denotes not
signiﬁcant and ∗P , 0.05, ∗∗P , 0.01, ∗∗∗P , 0.001.
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